2023 annual financial data

Seres Therapeutics 2023 Financial results

Direct answer

Revenue was 126.33M USD.

Operating income was -195.1M USD and net income was -113.72M USD.
Operating cash flow was -117.35M USD.

Get free Seres Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
126.33M USD
Operating income
-195.1M USD
Net income
-113.72M USD
Operating cash flow
-117.35M USD